Search
for
Sort by
Research 721–750 of 1000+
- Diagnostic approach to low‐renin hypertension
- 5α-Reductase inhibitors in androgenetic alopecia
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Women's midlife health Reframing menopause
- Clinical applications of antiandrogens
- Parkinson's disease and skin
- The ITGB6 gene: its role in experimental and clinical biology
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- EVALUATION OF CRUDE FLAXSEED (Linum usitatissimum L.) OIL IN BURN WOUND HEALING IN NEW ZEALAND RABBITS
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Trichotillomania in Children
- New approaches to the treatment of osteoporosis
- The rationale for physiological testosterone replacement in women
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- MicroRNA in skin diseases
- Cardiac morphologic alterations in acute minoxidil cardiotoxicity in miniature swine
- Androgen antagonists in androgen target tissues
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Prescribing testosterone and DHEA: The role of androgens in women
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Changes of androgens levels in menopausal women
- Post-finasteride syndrome: An emerging clinical problem
- New drugs under investigation for the treatment of alopecias
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Hirsutism: diagnosis and treatment
- Measurement of hair growth
- Topically Applied Minoxidil in Baldness
- Biotin Deficiency in a Patient with Short Bowel Syndrome during Home Parenteral Nutrition
- Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases